Objectives: To establish the molecular epidemiology and antimicrobial resistance pattern of extendedspectrum b-lactamase (ESBL)-producing Enterobacteriaceae harbouring bla CTX-M in Glasgow, Scotland.
Introduction
As highlighted by Xu et al.,
1 extended-spectrum b-lactamase (ESBL)-producing Enterobacteriaceae continue to show geographical variation and increasing diversification. Several studies have been performed to characterize ESBL-producing Enterobacteriaceae in the UK; however, none of these studies focused solely on isolates from Scotland. For example, Woodford et al. 2 collected 291 CTX-M-producing Escherichia coli from 42 UK centres; however, only 2 of these isolates were from Scotland. Younes et al. 3 investigated the prevalence of transferable bla CTX-M-15 from hospital-and community-acquired isolates in Edinburgh, Scotland, but only looked at Klebsiella pneumoniae. Therefore we sought to analyse whether ESBL-producing Enterobacteriaceae from Glasgow have similar molecular epidemiology, genetic characteristics and antimicrobial resistance patterns compared with previous British and worldwide studies.
Materials and methods
Enterobacteriaceae isolates from urine samples were collected over a 12 week period (November 2009 -January 2010) and susceptibility testing using standard disc diffusion methodology according to the CLSI guidelines was performed. 4 All Enterobacteriaceae resistant to both amoxicillin and cephalexin underwent further testing in order to phenotypically detect the presence of ESBLs. This involved the use of the double disc diffusion method, 5 MASTDISCS w ID ESBL detection disc diffusion test (Mast Diagnostics, Bootle, UK) and automated testing using Vitek w 2 (bioMérieux S.A., Marcy l'Éoile, France). Extended susceptibility testing was also performed on all ESBL-producing Enterobacteriaceae using Vitek w 2 according to CLSI guidelines. 4 Phenotypically confirmed ESBL-producing Enterobacteriaceae were screened by multiplex PCR for the presence of bla CTX-M genes according to the protocols described by Woodford et al. 6 Positive control strains were used for each PCR. Amplification was carried out using cell lysate with Promega Go-Taq polymerase (Promega, Southampton, UK), and selected E. coli genes were sequenced.
PFGE analysis was performed on selected isolates using a modified version of the technique described by Miranda et al. 7 The total bacterial DNA was digested with XbaI (Promega), and DNA fragments were separated on a 1% agarose gel in 0.5× TBE buffer using the CHEF DRII apparatus (Bio-Rad, Hertfordshire, UK). The pulse time was 2-50 s over a running time of 30 h. The fragmented DNA was run at a field strength of 6 V/cm for 22 h at 148C. After PFGE, the gels were stained with ethidium bromide and digital images of each gel were captured by Gel Doc 2000 (Bio-Rad). Isolates that clustered together with a Dice coefficient correlation of .85% were considered to belong to the same PFGE type. Fisher's exact test was used to assess differences in antibiotic resistance rates between the different types of ESBL-producing Enterobacteriaceae. P values ,0.05 were considered to be statistically significant. SPSS software, version 17 (SPSS) was used for statistical analysis.
Results
A total of 2053 Enterobacteriaceae isolates from urine samples were collected over a 12 week period. A total of 155 (7.5%) nonduplicate isolates were phenotypically confirmed as ESBLproducing Enterobacteriaceae. The 155 isolates consisted of 105 E. coli, 35 Klebsiella pneumoniae, 1 Klebsiella oxytoca, 8 Enterobacter sp., 2 Serratia sp., 2 Citrobacter sp., 1 Morganella morganii and 1 Proteus sp. We found that 131 (84.5%) ESBLproducing isolates contained genes encoding CTX-M enzymes and 24 (15.5%) produced non-CTX-M ESBLs (Table 1) . Further analysis of the bla CTX-M -positive isolates revealed that 103/131 (78.6%) were of the CTX-M group 1 type (G1), 1/131 (0.8%) was of the CTX-M group 2 type (G2) and 17/131 (13.0%) were of the group 9 type (G9). A further 10 (7.6%) of the bla CTX-Mproducing isolates expressed two enzymes simultaneously.
One of these enzymes was identified as CTX-M group 2; however, the other enzyme was not identified, therefore these organisms were classified as G2/Gx. Sequencing of two E. coli CTX-M G1 isolates revealed that both isolates expressed CTX-M-15. Similarly, sequencing of the E. coli CTX-M G2 isolate revealed CTX-M-2 expression, while sequencing of one E. coli CTX-M G9 isolate identified the expression of CTX-M-14.
A sample of 46/97 (47.4%) CTX-M-positive E. coli isolates were chosen for PFGE and demographic information regarding the source of the isolates was collated. Twenty isolates were chosen from CTX-M group 1, 15 isolates from CTX-M group 9, 10 isolates from CTX-M group G2/Gx and 1 isolate from CTX-M group 2. The PFGE results and the source of the isolates are shown in Figure 1 . There were eight clusters with similarity ranging from 54.36% to 73.75%. From the 46 E. coli isolates that were chosen for PFGE, 33/46 (71.7%) came from a hospital setting. Two-thirds of these samples were sent from the two acute care hospitals (22/33, 66.7%), with the remainder from two rehabilitation hospitals for the elderly. The majority of samples were from patients in the .75 age group (29/46, 63.0%). Similarly, the majority of samples were from female patients (33/46, 71.7%) and 40/46 (87.0%) were midstream urine specimens, with the remainder catheter urine specimens.
There were no statistically significant differences in antimicrobial resistance patterns among Enterobacteriaceae expressing CTX-M ESBL types when compared with Enterobacteriaceae expressing non-CTX-M ESBLs (Table 2 ). Table 3 shows that nitrofurantoin resistance was significantly greater in the non-CTX-M G1 E. coli isolates when compared with the G1 E. coli isolates (35.7% versus 13.0%; P ¼ 0.021); however, there were no differences in resistance rates for the other antibiotics.
Discussion
Data regarding the molecular epidemiology of ESBL-producing Enterobacteriaceae from Scotland, and specifically Glasgow, have been lacking. It has been assumed that the local epidemiology would be similar to that of the rest of UK; however, there has been some heterogeneity in the prevalence of CTX-M types throughout England, with the emergence of less common CTX-M types, such as CTX-M-2. The first published UK-wide study found that 85% of 291 Enterobacteriaceae expressing CTX-M enzymes were of the CTX-M-15 type, with a further 12% of isolates belonging to CTX-M group 9, consisting of CTX-M-9 and CTX-M-14. 2 Despite the fact that only two isolates from that study originated from Scotland, the results obtained in our study confirm Khanna et al. 20  26  17  16  47  3  302  216  279  197  241  166  169  7  186   135  137  153  154  157  87  54  1  175  33  48  2  201  59  291  399  12  380  347  396  141  306  328  322  331  341  374  77  151  140 191 G9  G1   ACH2  ACH2  GP  GP  GP  RH1  ACH1  GP  GP  RH1  GP  RH1  GP  ACH2  ACH2  GP  ACH1  ACH1  ACH1  RH1  ACH2  RH2  GP  ACH2  GP  GP  RH1  ACH1  ACH1  ACH1  ACH1  ACH1  ACH1  RH2  ACH2  RH1  GP  ACH1  RH1  ACH1  ACH2  RH1  ACH2  RH1  GP ESBL-producing Enterobacteriaceae in Glasgow, Scotland 575 JAC that cross-infection alone is the driver. It is possible that plasmid migration of CTX-M genes within the E. coli population is occurring. These results are similar to those of Ben-Ami et al., 10 but are in stark contrast to those of Xu et al.,
1 who found that 95% of E. coli isolates could be categorized into 23 clusters, including 7 major clusters, all with isolates that fulfilled the 85% cut-off to define clonality. In the present study, there is a small group of three isolates (153, 154 and 157) that appear to be genetically identical by PFGE, having the same CTX-M type and the same antibiogram (data not shown). Although these three samples were taken from patients at different hospitals, all three of these patients were resident on the same ward at some point during their admission, and indeed, two of these patients were resident on the same ward at the same time. As an adjunct to this study, PFGE of the 33/36 CTX-M G1 K. pneumoniae isolates did not show that the Glasgow isolates were clonally related to any of the Edinburgh K. pneumoniae isolates from the study by Younes et al. 3 (A. Hamouda and S. G. B. Amyes, unpublished results).
There are a few UK studies looking at the resistance patterns of different types of ESBL-producing Enterobacteriaceae, but none of these studies has focused solely on isolates from Scotland. Potz et al.
11 reviewed 1122 cephalosporin-resistant Enterobacteriaceae from 16 centres in London and south-east England and found that ciprofloxacin, gentamicin and nitrofurantoin resistance was greater in CTX-M-producing Enterobacteriaceae than in non-CTX-M-producing Enterobacteriaceae. In a multinational study of 983 isolates (90% of which were E. coli), Ben-Ami et al. 12 found that CTX-M-producing Enterobacteriaceae were more likely to be resistant to ciprofloxacin and less likely to be resistant to trimethoprim. Xu et al.
1 found that 93.4% of CTX-M-producing Enterobacteriaceae were resistant to ciprofloxacin, 91.4% to trimethoprim and 52.4% to gentamicin, and nine isolates displayed reduced susceptibility to carbapenems. There were no data for non-CTX-M-producing Enterobacteriaceae.
Relatively few studies have compared antibiotic resistance patterns among Enterobacteriaceae expressing different CTX-M genes. Woodford et al. 2 found that antibiotic resistance among CTX-M-15-producing Enterobacteriaceae was more substantial when compared with CTX-M-9-producing Enterobacteriaceae. Mean geometric MICs for the majority of antibiotics, including gentamicin and ciprofloxacin, was significantly greater in the CTX-M-15 cohort. This is in contrast with results from our study, which showed greater nitrofurantoin resistance in the non-G1 isolates. Pitout et al. 13 found that gentamicin and trimethoprim/sulfamethoxazole resistance among CTX-M group 1-producing Enterobacteriaceae was significantly greater than Enterobacteriaceae expressing CTX-M group 14 enzymes.
The main limitation of the study was an inability to perform multilocus sequence typing ('MLST') in order to identify the O25b-ST131 E. coli clone or UK epidemic strain A that has been implicated in several outbreaks locally and abroad. 2, 9 This would have provided conclusive data on whether the local spread of Enterobacteriaceae expressing CTX-M ESBL genes was similar to the clonal spread witnessed in England and elsewhere. Due to the inability to perform plasmid analysis, it is impossible to conclusively prove plasmid migration between our isolates. In addition, it was not possible to fully identify the CTX-M G2/Gx ESBL type. Similarly, it would have been ideal to perform molecular analysis of the Enterobacteriaceae expressing Khanna et al.
non-CTX-M ESBL genes to assess the prevalence of other ESBL types, such as bla SHV and bla TEM .
In conclusion, as far as we are aware, this is the first study to perform a molecular analysis of ESBL-producing Enterobacteriaceae obtained from the west of Scotland. It can be confirmed that the dominant local genotype is CTX-M group 1, with the likelihood that CTX-M-15 is the predominant member, similar to studies from the rest of the UK. However, there is little evidence of clonal spread of E. coli in this population. Studies to further characterize local ESBL-producing Enterobacteriaceae, including identification of the O25b-ST131 E. coli clone, are required.
